Part 13/14:

The story of AI giants like OpenAI exemplifies a broader pattern: noble beginnings marred by corporate incentives that favor wealth accumulation over scientific integrity. While the original vision was to democratize AI benefits, recent developments suggest a pivot towards maximizing profits, sometimes at odds with ethical considerations.

The international landscape—with China’s open models contrasting with US’s proprietary approaches—adds layers of strategic complexity. The entire sector appears mired in a cycle of valuation inflation, funding rounds, and strategic moves that resemble financial bubbles more than scientific pursuits.